Sofia Merajver

Q: What Schools Are Affiliated With Sofia Merajver

Sofia Merajver is affiliated with the following schools: Emory University, University of Michigan, University of Buenos Aires, Kwame Nkrumah University of Science and Technology

Sofia Merajver's AcademicInfluence.com Rankings

Sofia Merajver

Medical

#3100

World Rank

#3555

Historical Rank

Oncology

#227

World Rank

#235

Historical Rank

medical Degrees

Download Badge

Medical

Sofia Merajver's Degrees

Doctorate Medicine University of Buenos Aires

Why Is Sofia Merajver Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sofia Diana Merajver is an American-Argentine medical oncologist. She is the GreaterGood Breast Cancer Research Professor and director of the Breast and Ovarian Cancer Risk Evaluation Program at Michigan Medicine. In 2022, Merajver was elected a Fellow of the American Association for the Advancement of Science.

(See a Problem?)

Sofia Merajver's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds (1996) (866)
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. (2017) (554)
BRCA1 regulates human mammary stem/progenitor cell fate (2008) (477)
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. (2011) (439)
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours (1995) (412)
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. (2002) (369)
BRCA2 germline mutations in male breast cancer cases and breast cancer families (1996) (363)
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. (2002) (349)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. (2021) (346)
RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. (2000) (341)
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. (2006) (322)
Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. (1995) (318)
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. (2016) (306)
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. (2000) (304)
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. (2020) (281)
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. (1999) (274)
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. (2006) (265)
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. (2001) (260)
Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants (2000) (225)
Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. (2013) (220)
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. (2018) (216)
Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. (2002) (215)
Persistent E-Cadherin Expression in Inflammatory Breast Cancer (2001) (212)
Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. (1996) (205)
CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling (2007) (183)
RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. (2000) (175)
Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988–2008) (2012) (174)
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy (2010) (169)
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. (2003) (168)
Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes. (2016) (163)
Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma (2004) (160)
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. (2005) (159)
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. (2014) (158)
Copper deficiency as an anti-cancer strategy. (2004) (153)
Distinct regions of allelic loss on 13q in prostate cancer. (1996) (151)
Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. (2003) (151)
WISP3 is a novel tumor suppressor gene of inflammatory breast cancer (2002) (149)
Single-cell Migration Chip for Chemotaxis-based Microfluidic Selection of Heterogeneous Cell Populations (2015) (137)
Assessment of genetic testing and related counseling services: current research and future directions. (2004) (133)
Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. (2006) (132)
Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. (2002) (126)
Down-regulation of Enhancer of Zeste-2 decreases growth of estrogen receptor negative invasive breast carcinoma and requires BRCA1 (2008) (117)
A Hidden Feedback in Signaling Cascades Is Revealed (2008) (114)
Sentinel node biopsy prior to neoadjuvant chemotherapy. (2003) (114)
RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast (2005) (114)
Logic-based models in systems biology: a predictive and parameter-free network analysis method. (2012) (110)
Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia. (2009) (110)
The Role of Copper Suppression as an Antiangiogenic Strategy in Head and Neck Squamous Cell Carcinoma (2001) (110)
Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. (1996) (107)
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer (2006) (106)
Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer (2004) (106)
Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade. (2003) (105)
The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. (2005) (104)
Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. (2002) (102)
Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer (2004) (101)
Signaling properties of a covalent modification cycle are altered by a downstream target (2010) (100)
Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience. (1997) (100)
Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. (1995) (99)
WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer (2003) (98)
Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. (2011) (95)
Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and Caveolin-1 (2005) (93)
RhoC Induces Differential Expression of Genes Involved in Invasion and Metastasis in MCF10A Breast Cells (2004) (90)
WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. (2004) (89)
Radiotherapy and antiangiogenic TM in lung cancer. (2002) (88)
Urban-rural differences in breast cancer incidence in Egypt (1999-2006). (2010) (85)
RhoA-GDP Regulates RhoB Protein Stability (2008) (83)
Load-Induced Modulation of Signal Transduction Networks (2011) (83)
Pomegranate Fruit Extract Impairs Invasion and Motility in Human Breast Cancer (2009) (78)
Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. (2006) (74)
Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. (2002) (73)
A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results. (2008) (73)
Cancer‐specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning (2001) (73)
Multifaceted Role of Rho Proteins in Angiogenesis (2005) (73)
Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer (2009) (67)
Clinical and epidemiologic profile of breast cancer in Tanzania. (2010) (67)
RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck (2006) (67)
Genetic counseling for BRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process (2005) (67)
RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells (2012) (67)
Breast cancer risk reduction. (2010) (66)
Urban–rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt (2010) (66)
Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. (2008) (66)
Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer (2016) (65)
Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers (2010) (64)
Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells (2005) (63)
Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1. (1996) (61)
p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior. (2011) (60)
Individual and Neighborhood Socioeconomic Status and Healthcare Resources in Relation to Black-White Breast Cancer Survival Disparities (2013) (60)
Control of copper status for cancer therapy. (2005) (58)
Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer (2007) (57)
NCCN Clinical Practice Guidelines in Oncology for Breast Cancer Risk Reduction (2010) (57)
Construction of a transcription map surrounding the BRCA1 locus of human chromosome 17. (1995) (57)
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression (2012) (56)
Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990–2008 (2012) (55)
Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. (2016) (55)
Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis (2010) (54)
Cancer classification in the genomic era: five contemporary problems (2015) (54)
Long signaling cascades tend to attenuate retroactivity. (2011) (53)
Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. (2003) (51)
Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. (2014) (51)
IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling (2019) (50)
Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999–2008) (2013) (49)
Oral Contraceptives and the Risk of Breast Cancer in BRCA 1 and BRCA 2 Mutation Carriers (2002) (47)
Multisite Phosphorylation Provides an Effective and Flexible Mechanism for Switch-Like Protein Degradation (2010) (45)
Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model. (2003) (45)
High Proportion of Inflammatory Breast Cancer in the Population‐Based Cancer Registry of Gharbiah, Egypt (2009) (44)
Triple‐Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience (2015) (43)
On the role of cell signaling models in cancer research. (2009) (43)
Cancer Therapy With Tetrathiomolybdate: Antiangiogenesis by Lowering Body Copper—A Review (2002) (41)
Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa (2018) (41)
Detection of Epstein-Barr Virus in Rapidly Growing Fibroadenomas of the Breast in Immunosuppressed Hosts (2002) (41)
Kinase inhibitors can produce off-target effects and activate linked pathways by retroactivity (2011) (40)
Trends in Breast Cancer Stage and Mortality in Michigan (1992–2009) by Race, Socioeconomic Status, and Area Healthcare Resources (2013) (40)
Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors. (2016) (40)
RhoC Expression and Head and Neck Cancer Metastasis (2009) (40)
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer (2009) (39)
Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania (2013) (39)
Global mental health: Global strengths and strategies Task-shifting in a shifting health economy. (2011) (38)
Breast cancer risk reduction, version 2.2015 clinical practice guidelines in oncology clinical practice guidelines in oncology (2015) (38)
Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling (2016) (37)
Picosecond-resolution fluorescence lifetime imaging microscopy: a useful tool for sensing molecular interactions in vivo via FRET. (2007) (37)
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm (2009) (37)
Breast cancer characteristics at diagnosis and survival among Arab–American women compared to European– and African–American women (2009) (36)
CCN6 (WISP3) as a New Regulator of the Epithelial Phenotype in Breast Cancer (2007) (35)
Traditional Herbalists and Cancer Management in Kumasi, Ghana (2012) (35)
Effects of postpartum mobile phone‐based education on maternal and infant health in Ecuador (2016) (35)
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. (2020) (35)
The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck. (2005) (34)
Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative. (2019) (33)
Loss of PTEN promotes formation of signaling-capable clathrin-coated pits (2017) (31)
Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco. (2011) (30)
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy (2021) (30)
High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions (2020) (29)
Clinical predictors of long-term survival in HER2-positive metastatic breast cancer (2016) (29)
Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients (2008) (29)
Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience. (1997) (28)
Breast Cancer in Ghana: Demonstrating the Need for Population-Based Cancer Registries in Low- and Middle-Income Countries (2017) (28)
Association of Inflammatory and Noninflammatory Breast Cancer with Socioeconomic Characteristics in the Surveillance, Epidemiology, and End Results Database, 2000–2007 (2011) (28)
Genetic determinants of aggressive breast cancer. (2008) (27)
The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study (2016) (26)
An Anticopper Antiangiogenic Approach for Advanced Cancer in Spontaneously Occurring Tumors Using Tetrathiomolybdate: A Pilot Study in a Canine Animal Model (2004) (26)
Disparities in genetic services utilization in a random sample of young breast cancer survivors (2018) (26)
Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women (2015) (26)
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm. (2009) (26)
Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy. (2005) (25)
Tracking the tumor invasion front using long-term fluidic tumoroid culture (2017) (25)
Engineered Tools to Study Intercellular Communication (2020) (25)
Individual and family characteristics associated with BRCA1/2 genetic testing in high‐risk families (2013) (25)
Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. (2009) (25)
Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer (2013) (25)
RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells* (2016) (25)
Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics (2016) (24)
Establishing effective registration systems in resource-limited settings: cancer registration in Kumasi, Ghana. (2013) (24)
Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer. (2009) (24)
Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America. (2010) (24)
Characterizing breast cancer treatment pathways in Kumasi, Ghana from onset of symptoms to final outcome: outlook towards cancer control. (2014) (23)
Rho Proteins and Cell-Matrix Interactions in Cancer (2007) (23)
Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study (2012) (23)
Antiangiogenic Tetrathiomolybdate Protects against Her2/neu-Induced Breast Carcinoma by Hypoplastic Remodeling of the Mammary Gland (2009) (23)
Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients. (2009) (22)
Molecular determinants of the inflammatory breast cancer phenotype. (2008) (22)
Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes (2019) (22)
Breast Cancer by Age at Diagnosis in the Gharbiah, Egypt, Population-Based Registry Compared to the United States Surveillance, Epidemiology, and End Results Program, 2004–2008 (2015) (22)
Physiological fluorescence lifetime imaging microscopy improves Förster resonance energy transfer detection in living cells. (2009) (21)
UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer (2016) (21)
A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche. (2019) (21)
Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening (2013) (21)
Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database (2020) (21)
Raman spectroscopic study of the conformational order in hexadecane solutions (1981) (21)
Knowledge gained after a brief CME module on breast cancer diagnosis. (2006) (20)
Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not. (2011) (20)
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia (2013) (20)
Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study (2018) (19)
A Comparison of Criteria to Identify Inflammatory Breast Cancer Cases from Medical Records and the Surveillance, Epidemiology and End Results Data base, 2007–2009 (2014) (19)
"Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells. (2015) (19)
Direct antitumour activity of zoledronic acid: preclinical and clinical data (2011) (18)
Public and Professional Educational Needs for Downstaging Breast Cancer in Egypt (2012) (17)
Mechanotransduction-Induced Reversible Phenotypic Switching in Prostate Cancer Cells. (2017) (17)
Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study (2017) (17)
Risk Factors for Chronic Mastitis in Morocco and Egypt (2013) (17)
Informing video topics and content on maternal infant and young child nutrition and handwashing: Situational analysis and formative research in Maradi Niger. (2016) (16)
Breast Cancer Risk Reduction, Version 2.2015. (2015) (16)
Breast Cancer and African Ancestry: Lessons Learned at the 10-Year Anniversary of the Ghana-Michigan Research Partnership and International Breast Registry (2016) (15)
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines (2008) (15)
Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells. (2019) (15)
A YAC-, P1-, and cosmid-based physical map of the BRCA1 region on chromosome 17q21. (1995) (15)
The use of mammography in breast preservation in locally advanced breast cancer. (1996) (14)
Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry (2018) (14)
Inferring the Effects of Honokiol on the Notch Signaling Pathway in SW480 Colon Cancer Cells (2014) (14)
Approach to Equilibrium of a Boltzmann-Equation Solution (1981) (13)
Heterogeneity at the invasion front of triple negative breast cancer cells (2020) (13)
Breast cancer risk reduction. (2010) (13)
Chronic Mastitis in Egypt and Morocco: Differentiating between Idiopathic Granulomatous Mastitis and IgG4‐Related Disease (2016) (13)
Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference (2017) (13)
Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology. (2007) (12)
Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency. (2007) (12)
Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma. (2006) (12)
Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana (2018) (11)
Engaging patients via mobile phone technology to assist follow-up after hospitalization in Quito, Ecuador. (2012) (10)
Rethinking the war on cancer: multidisciplinary collaborations between biologists and physical scientists. (2012) (10)
Risk of Breast and Ovarian Cancer in Women With Strong Family Histories (2001) (10)
Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti‐RhoC silencing RNA and presentation of EPPT1 peptide on “smart” particles (2018) (10)
Retroactive Signaling in Short Signaling Pathways (2012) (10)
Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa (2019) (9)
Unraveling the complex regulatory relationships between metabolism and signal transduction in cancer. (2012) (9)
Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients. (2011) (9)
Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana (2019) (9)
Reliability of medical records in diagnosing inflammatory breast cancer in Egypt (2017) (9)
Purification and structural characterization of herpes simplex virus glycoprotein C. (1987) (9)
Genetic/familial high-risk assessment (2010) (8)
Breast cancer risk assessment: a guide for clinicians using the NCCN Breast Cancer Risk Reduction Guidelines. (2003) (8)
Ultrahigh‐molecular‐weight polyethylene: Raman spectroscopic study of melt anisotropy (1986) (8)
Inflammatory breast cancer: advances in molecular genetics and treatment (2006) (8)
Norstictic acid is a selective allosteric transcriptional regulator (2021) (8)
Rho Proteins in Cancer (2010) (8)
Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations (2018) (8)
The Impact of Nathan Mantel's "The Detection of Disease Clustering and a Generalized Regression Approach". (2016) (8)
A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer (2020) (7)
The role of cognitive appraisal and worry in BRCA1/2 testing decisions among a clinic population (2007) (7)
Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations. (1995) (7)
Global comparative healthcare effectiveness research: Evaluating sustainable programmes in low & middle resource settings (2013) (7)
Integrated Systems and Technologies : Mathematical Oncology p 38 g Promotes Breast Cancer Cell Motility and Metastasis through Regulation of RhoC GTPase , Cytoskeletal Architecture , and a Novel Leading Edge Behavior (2011) (7)
Survival of Inflammatory Breast Cancer Patients Compared to Non‐inflammatory Breast Cancer Patients in Egypt (2011) (7)
Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients (2011) (7)
The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin’s lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study (2014) (6)
Metastatic Dedifferentiated Chordoma With Elevated &bgr;-hCG: A Case Report (2002) (6)
Molecular determinants of drug response in TNBC cell lines (2019) (6)
Intermolecular interactions and Fermi resonance in methylene groups (1982) (6)
Familial breast cancer. Approaching the isolation of a susceptibility gene (1994) (6)
Murine muscle stem cell response to perturbations of the neuromuscular junction are attenuated with aging (2021) (6)
Outcomes following breast conservation versus mastectomy in BRCA1/2 carriers with early-stage breast cancer (2008) (6)
Health Insurance and Discrimination Concerns and BRCA 1 / 2 Testing in a Clinic Population 1 (2002) (5)
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography. (2020) (5)
Risk factors for inflammatory and non-inflammatory breast cancer in North Africa (2020) (5)
One-Hit Effects and Cancer (2010) (5)
Germline BRCA 1 Mutations and Loss of the Wild-Type Allele in Tumors from Families with Early Onset Breast and Ovarian Cancer 1 (2005) (5)
Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer? (2020) (5)
Familial breast cancer. Approaching the isolation of a susceptibility gene. (1994) (4)
Inflammatory breast cancer: what are the treatment options? (2009) (4)
BRCA-associated cancer risk: molecular biology and clinical practice. (1999) (4)
Single Cell Deconstruction of Muscle Stem Cell Heterogeneity During Aging Reveals Sensitivity to the Neuromuscular Junction (2020) (4)
Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy. (2009) (4)
Shock wave impact on the viability of MDA-MB-231 cells (2020) (4)
Random-walk model of the phase transition of hydrocarbon chains on a lattice (1981) (4)
Chromosomal mapping of the rat Slc 4 a family of anion exchanger genes (1996) (4)
Characterization of hexadecanoic acid perdeuterated from carbon eight to carbon sixteen: a novel conformational probe for amphipathic systems (1981) (4)
Spectroscopic study of α‐ and β‐phase isotactic polypropylene and of atactic polypropylene in solution (1985) (4)
CHEK2 screening: do not think so globally yet. (2008) (4)
Chromosomal mapping of the rat Slc4a family of anion exchanger genes, Ael, Ae2, and Ae3 (1996) (4)
Knowledge of risk factors and modes of gene transmission among women at risk for hereditary breast and ovarian cancer syndrome. (2011) (3)
Improving FRET detection in living cells (2009) (3)
Tamoxifen a nd C hemotherapy f or A xillary N ode-Negative, Estrogen R eceptor-Negativ e B reast C ancer: F indings F rom National S urgical A djuvant B reast a nd B owel P roject B -23 (2001) (3)
Abstract 4834: Single cell multiplex gene expression analysis to unravel heterogeneity of PDX samples established from tumors of breast cancer patients with different ethnicity (2015) (3)
The impact of retroactivity on the input/output static characteristics of a signaling component (2010) (3)
From in vitro to in silico and back again: Using biological and mathematical synergy to decipher breast cancer cell motility (2010) (3)
A phase II trial of Tetrathiomolybdate [TM] after cytoreductive surgery for malignant pleural mesothelioma (MPM). (2004) (3)
Erratum to: Public and Professional Educational Needs for Downstaging Breast Cancer in Egypt (2012) (3)
Progress toward isolation of a breast cancer susceptibility gene, BRCA1. (1994) (3)
Impact of between-tissue differences on pan-cancer predictions of drug sensitivity (2019) (3)
P2.98. Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell invasion and promoting tumor cell anoikis (2009) (3)
Initial Findings from a High Genetic Risk Prostate Cancer Clinic. (2021) (3)
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer (2022) (2)
Abstract 3236: Macrophages increase the expression of RhoC in inflammatory breast cancer leading to increased migration (2016) (2)
Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer. (1996) (2)
Genetic Testing and Surveillance of Young Breast Cancer Survivors and Blood Relatives: A Cluster Randomized Trial (2020) (2)
Substrate-induced modulation of signal transduction networks (2011) (2)
Abstract LB-59: Distinct pathways differentiate the CD44+ mesenchymal-like from the ALDH+ epithelial-like phenotype of triple negative breast cancer stem cells (2014) (2)
Sensing cellular function and molecular activity in vivo using fluorescence lifetime imaging microscopy (FLIM) (2005) (2)
Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry (2021) (2)
Inflammatory Breast Cancer Phenotype Mammary Epithelial Cells That Partially Recapitulates the RhoC GTPase , a Novel Transforming Oncogene for Human Updated (2000) (2)
RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers (2021) (2)
Tumor and Stem Cell Biology Histone Methyltransferase EZH 2 Induces Akt-Dependent Genomic Instability and BRCA 1 Inhibition in Breast Cancer (2011) (2)
Abstract P6-12-14: Comparative analysis of breast cancer phenotypes in African American, White American, and African patients- Correlation between African ancestry and triple negative breast cancer (2016) (2)
Theory of the conformational order of single component sphingomyelin bilayers. (1981) (2)
Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial (2019) (2)
Suicide prevention and mood disorders: Self‐exclusion agreements for firearms as a suicide prevention strategy (2021) (2)
Abstract 72: Amino terminus of SEPT9_i1 impacts cellular localization: Implications for mammary tumorigenesis (2012) (1)
Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer (2022) (1)
Abstract 1446: Glycogen accumulation in aggressive breast cancers under hypoxia (2018) (1)
Creating Models to Identify New Therapeutic Options for Aggressive African Breast Cancers (2018) (1)
The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin’s lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study (2014) (1)
Abstract 1700: Novel microfluidic blood-brain niche to study breast cancer metastasis to the brain (2016) (1)
Abstract 4518: IL-4/IL-13 stimulated tumor-associated macrophages enhance breast cancer cell invasion through Rho-GTPase signaling (2019) (1)
Abstract 1327: UM-9107: A selective wild-type and T315I Bcr-Abl inhibitor with in vivo activity against chronic myelogenous leukemia (2019) (1)
MEK is a promising target in the basal subtype of bladder cancer (2020) (1)
Breast Cancer Survival by Inflammatory Status, Sociodemographic, Tumor, and Treatment Characteristics in the Surveillance, Epidemiology, and End Results (SEER) Database, 1990-2008 (2012) (1)
Conquering the challenges of genotypic and phenotypic tumor heterogeneity to realize the promise of personalized cancer therapy: the role of academia. (2017) (1)
Test of InheRET, an online tool to facilitate NCCN Guideline compliant referrals for cancer genetic counseling. (2019) (1)
Abstract P6-08-50: Clinical predictors of long-term survival in Her2-positive (HER2+) metastatic breast cancer (MBC) (2015) (1)
Implementation of INHERET, an Online Family History and Cancer Risk Interpretation Program for Primary Care and Specialty Clinics. (2022) (1)
Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More Than 10 Years (2021) (1)
Differences in Reliability of Reproductive History Recall Among Women in North Africa. (2009) (1)
7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy (2010) (1)
What Should Be Modeled in Cancer (2017) (1)
Depression Risk and Cancer in Ecuador: The Protective Role of Social Support (2015) (1)
Characteristics of breast cancer in Ghana and prevalence of aggressive disease and high mortality. (2014) (1)
Making the case for integrated assessments of the biological, social, and system determinants of treatment for breast cancer to understand and improve outcomes in patients everywhere (2012) (1)
Reliability of medical records in diagnosing inflammatory breast cancer in Egypt (2015) (1)
NCCN Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology (2010) (1)
Transcript identification in the BRCA1 candidate region (1995) (1)
PKC and Breast Cancer (2010) (1)
Social Undermining and Intimate Partner Support Predict Depression in Cancer Patients (2015) (1)
Bisphosphonates in Breast Cancer: From Metastasis to Prevention (2010) (1)
Introduction on Angiogenesis in Breast Cancer (2005) (0)
Rapid organoid development, drug screening, and neoadjuvant chemotherapy response prediction for patients with locally advanced bladder cancer. (2020) (0)
Beyond triple-negative breast cancer and African ancestry: Tumor phenotypes among internationally diverse patient populations. (2017) (0)
Abstract 1444: RhoC regulation of inflammatory breast cancer metabolism (2018) (0)
Abstract P6-07-01: Withdrawn (2018) (0)
Oncogenes in the Development of Breast Cancer (2002) (0)
PD47-11 RAPID ORGANOID DEVELOPMENT, DRUG SCREENING, AND NEOADJUVANT CHEMOTHERAPY RESPONSE PREDICTION FOR PATIENTS WITH LOCALLY-ADVANCED BLADDER CANCER (2020) (0)
Abstract 5193: p38 gamma is a novel driver of breast cancer metastasis by modulating cellular motility (2010) (0)
Microarray analysis of RhoC-transformed mammary epithelial cells suggests molecular mechanisms of inflammatory breast cancer (2001) (0)
Abstract 4907: Elucidating the role of retroactive signaling and kinase inhibitors on off-target drug effects (2011) (0)
Abstract PS7-06: Incidence and survival of inflammatory breast cancer between 1973 - 2015 in the surveillance, epidemiology and end results (SEER) database (2021) (0)
Abstract 1639: Androgen receptor and ALDH1 expression among internationally diverse patient populations (2018) (0)
Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-CyclophosphamideinPatientswithClinicalStage IIB-IIIC BreastCancer (2009) (0)
Abstract 1695: Quantification of mitochondria in MCF-10A, MDA-MB-231, and SUM149 cells to understand potential defects in oxidative phosphorylation in cancer. (2013) (0)
Abstract 5769: Modeling the tumor invasion front using 3D fluidic tumoroid culture of cancer cells (2017) (0)
Real-time drug testing using patient-derived organoids from resected breast cancer brain metastases. (2021) (0)
Further perspectives on inflammatory breast cancer (2007) (0)
Abstract 1322: Comparison of brain extracellular matrices in a blood brain barrier organ on a chip model (2023) (0)
A phase II trial of tetrathiomolybdate (TM) in metastatic head & neck cancer (MHNC) patients (pts) after treatment with platinum & 5-fluorouracil (P&5FU) (2008) (0)
WHAT’S NEW IN THE MANAGEMENT OF INOPERABLE INFLAMMATORY (IBC) AND LOCALLY ADVANCED BREAST CANCER (LABC) (2021) (0)
Abstract 1187: Optimizing gemcitabine in metastatic TNBC by rational PI3K/AKT combination (2021) (0)
Author response: Murine muscle stem cell response to perturbations of the neuromuscular junction are attenuated with aging (2021) (0)
Biologic diversity of breast cancers in women with African ancestry. (2018) (0)
Abstract 1203: Metastasis-associated oncogene RhoC as a regulator of glutamine metabolism in the inflammatory breast cancer cell line SUM149 (2015) (0)
Abstract 4925: The natural enzyme sequestration in signaling cascades provides inherent opportunities for off-target effects induced by kinase inhibitors (2012) (0)
Response to Comment on “‘Load-Induced Modulation of Signal Transduction Networks’: Reconciling Ultrasensitivity with Bifunctionality?” (2012) (0)
Abstract 4363: Effects of the small GTPase RhoC on inflammatory breast cancer metabolism (2019) (0)
Tracking the tumor invasion front using long-term fluidic tumoroid culture (2017) (0)
Prevention of mammary tumorigenesis by aqueous and lipid pomegranate fruit extracts (PFE's): In vitro and in vivo studies (2007) (0)
Lymphatic capillary invasion assay by a single cell migration chip (2012) (0)
Erratum to: Public and Professional Educational Needs for Downstaging Breast Cancer in Egypt (2012) (0)
Abstract 4785: Disrupting redox regulated cancer stem cell state equilibrium by co-inhibition of glycolysis and thioredoxin/glutathione antioxidant pathways (2017) (0)
Traditional Herbalists and Cancer Management in Kumasi, Ghana (2012) (0)
Abstract 3030: Integrated in vitro and in silico screening of breast cancer reveals serine metabolism as a precision oncology target (2022) (0)
Development of a high-throughput radial migration device (2020) (0)
IN20 FROM SINGLE CELL MOTILITY TO SIGNALLING AND METABOLIC INTEGRATION: HOW MATHEMATICAL AND PHYSICAL MODELS CAN HELP CONTROL METASTASES IN PERSONALIZED MEDICINE (2013) (0)
Abstract 1179: Macrophage conditioned media increases the expression of a metastasis-associated oncogene, RhoC, and the migration of inflammatory breast cancer cells (2014) (0)
HSV : herpes simplex virus Reactivation : HSV DNA in sensory ganglia neurons directs synthesis of mRNA molecules that encode proteins required for HSV DNA replication and assembly of daughter virions (2013) (0)
Abstract 1813: Frequency and risk factors of male breast cancer in Egypt and Morocco (2010) (0)
Abstract 595: Targeting metabolic vulnerability in brain-metastatic HER2+ breast cancer (2023) (0)
Abstract 5536: KB-164, a novel and highly potent Src family kinase inhibitor, reduces cancer cell invasion and abrogates downstream oncogenic pathways in triple negative breast cancer (2015) (0)
ANALYSIS OF THE CONFORMATION OF ISOTACTIC AND ATACTIC POLY (PROPYLENE) SOLUTIONS AND OF POLY (ETHYLENE) AT HIGH PRESSURE BY RAMAN SPECTROSCOPY. (1982) (0)
Investigating RhoC-GTPase’s role in the metastasis of head and neck squamous cell carcinoma (2006) (0)
Abstract 2044: Lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) modulates VEGF-C and VEGF-D secretion in the triple negative breast cancer cell line MDA-MB-231 (2018) (0)
Abstract 1812: Urban-rural distribution of cancer profiles in Gharbiah, Egypt (2010) (0)
High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions (2020) (0)
Integration of high-content fluorescence imaging into the metabolic flux assay reveals insights into mitochondrial properties and functions (2019) (0)
Abstract 3371: Aldh expressing stem cells mediate tumor initiation and metastasis in triple negative breast cancers across different ethnicities (2017) (0)
Abstract 1485: Identification of p38γ as a metastatic oncogene: Mechanism of action and clinical implications (2011) (0)
OTHR-13. IMPACT the brain: improving metastatic breast cancer patient access to coordinated treatment (2021) (0)
Abstract 38: Molecular determinants of drug response in TNBC cell lines (2020) (0)
Tumor Growth and Angiogenesis Copper Deficiency Induced by Tetrathiomolybdate Suppresses Updated (2002) (0)
Abstract 6037: Identification of collateral lethal targets in cancers using integrated machine learning and flux analysis platform for personalized metabolic therapy (2023) (0)
Abstract 1194: MEK inhibition in combination with PI3K/AKT/MTOR is a promising therapeutic in basal bladder cancer (2021) (0)
Abstract 3842: RhoC is an essential determinant of breast cancer stem cell abundance and metastatic potential (2011) (0)
A lipopeptidomimetic of transcriptional activation domains selectively disrupts Med25 PPIs (2023) (0)
hysiological fluorescence ifetime imaging icroscopy improves örster resonance energy ransfer detection in iving cells (2009) (0)
Abstract 5223: Elucidating the complex cross-talk between the MAPK and PIK3 pathways. (2013) (0)
The Conformational order in Hexadecane Solutions and Polyethylene (1984) (0)
Bilingual Educational Tool for Breast Cancer Genetics (1997) (0)
Breast cancer screening recommendations: dynamic extrapolation of limited data (2010) (0)
Abstract 3072: Functional assays of drug sensitivity in real-time from patient material for precision oncology in bladder cancer (2022) (0)
Abstract 3852: Prevalent loss of BRCA1 and BRCA2 expression in African TNBC suggests their prominent role in sporadic carcinogenesis (2015) (0)
Abstract 37: Alterations in the metabolism of highly motile cells: Implications for cancer metastasis (2010) (0)
Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer (2020) (0)
Why are Rho proteins important in cancer? (2004) (0)
O114. Pre-clinical development of a bi-functional, cancer cell homing, PKCe inhibitory peptide for the treatment of head and neck cancer (2009) (0)
Cancer classification in the genomic era: five contemporary problems (2015) (0)
Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics (2016) (0)
Abstract 4977: Chronic mastitis in North Africa: Geographic overlap and a potential precursor comorbidity of inflammatory breast cancer (2014) (0)
Abstract PL03-03: Differences in breast cancer stem cell signaling and metabolic integration associated with African versus European ancestry (2014) (0)
Rational drug combination therapy for improved efficacy and delayed resistance in triple negative breast cancer. (2018) (0)
Abstract 4012: EGFR inhibition in combination with PI3K/AKT/mTOR and/or Bcl-2 inhibition is a promising novel therapeutic approach for inverted sinonasal papillomas and associated sinonasal carcinomas (2022) (0)
Abstract 2012: Off-target drug effects due to retroactivity in signaling pathways (2010) (0)
Abstract 5239: Unraveling the complex regulatory relationship between PI3K signaling and metabolic transformation in breast cancer. (2013) (0)
Pan-cancer predictions of MEK inhibitor sensitivity are partially driven by between-tissue differences (2019) (0)
Abstract 5156: RhoC decreases tight junction stabilization in breast cancer cells, revealing a potential therapeutic target (2018) (0)
Abstract 5164: Using metabolomic flux to uncover new targets for the modulation of breast cancer metastasis (2012) (0)
Abstract 1040: Differential levels of glycogen in breast cancer cell lines: A potential new target (2016) (0)
Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer 1 (2003) (0)
Abstract 3103: Analysis of breast cancer lines and PDXs using a blood brain niche (µm-BBN) microfluidic device and algorithms to aid diagnosis of brain metastatic potential (2018) (0)
RhoC disrupts tight junction formation and epithelial polarity in inflammatory breast cancer (2008) (0)
Development of an Enhanced-Throughput Radial Cell Migration Device (2020) (0)
Abstract 4117: Mechanisms of acquired resistance to c-Src kinase inhibitor in triple negative breast cancer (2017) (0)
Abstract 433: Glycogen accumulation in aggressive breast cancers during hypoxic exposure (2017) (0)
Significance of Pathways Leading to RhoC Overexpression in Breast Cancer (2008) (0)
RhoA regulates RhoB through a RhoGDI α-dependent mechanism (2007) (0)
Abstract 5622: Effect of novel RhoC inhibitor on breast cancer progression and metastasisin vivo (2012) (0)
Abstract 3989: Identification of biomarkers for UM-164 in triple-negative breast cancer (2019) (0)
Abstract 2139: RhoC is a determinant of metastatic potential and affects the abundance of breast cancer stem cells (2012) (0)
p38 MAPK is altered transcriptionally, translationally, and post-translationally in inflammatory breast cancer – significance and implications. (2009) (0)
Abstract 915: AKT inhibition sensitizes TNBC cells with acquired drug resistance to UM-164 (2018) (0)
Heterogeneity at the invasion front of triple negative breast cancer cells (2020) (0)
Abstract 4647: Identifying drug targets in sarcoma using machine learning and cell phenotype-based compound screening (2018) (0)
A plausible mechanism for genome plasticity: lessons from parasitic wasps (2007) (0)
Abstract 2616: RhoC decreases tight junction stabilization in breast cancer cells, revealing a potential therapeutic target (2020) (0)
Abstract 1397: The effects of mevalonate pathway inhibitors on the motility and invasion of aggressive breast cancers (2011) (0)
Lentivirus-mediated RNA interference of EZH2 inhibits proliferation, invasion, and decreases aneuploidy in breast cancer cells (2008) (0)
Genetic Determinants of Inflammatory Breast Cancer (2002) (0)
Abstract 5511: Cancer care-seeking patterns in Kumasi, Ghana (2012) (0)
Abstract 3174: Visualization of the activation/deactivation cycle of RhoC in inflammatory breast cancer (2010) (0)
Abstract 1518: Multiethnic triple negative breast cancer comparisons of gene expression shows enrichment of distinct pathways in ALDH1+ subpopulations compared to CD44+/CD24-/EpCAM+ (2015) (0)
Abstract 4018: Pan-cancer predictions of drug sensitivity based on protein-coding and non-coding RNA biomarkers (2019) (0)
Insights into the modular design of kinase inhibitors and application to Abl and Axl. (2022) (0)
Correction: Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana (2018) (0)
Blood–Brain Barrier Remodeling in an Organ‐on‐a‐Chip Device Showing Dkk1 to be a Regulator of Early Metastasis (2023) (0)
DCIS and hereditary susceptibility for breast cancer (2015) (0)
Capture circulating tumor cells on glass (2013) (0)
RhoCGTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck (2006) (0)
Molecular relaxation dynamics of aqueous macrocycles: 15C5-Water mixtures (1983) (0)
Abstract 357: A systems biology approach for rational molecular network inference (2014) (0)
Abstract 5592: Expansion and characterization on ALK positive NSCLC circulating tumor cells isolated using a size based inertial microfluidic Labyrinth device (2023) (0)
Reply by Authors. (2021) (0)
Outcomes of a Cluster Randomized Trial in Young Breast Cancer Survivors and Blood Relatives: Surveillance and Genetic Services (2019) (0)
Evaluating specialty referral, research involvement, and PROs in a CNS-involved metastatic breast cancer care coordination program. (2021) (0)
- 4045 TITLE : Defining the Smallest Common Region of Chromosome 17 p that is Deleted in Sporadic Breast Tumors (0)
Breast Cancer Risk Reduction , Version 2 . 2015 Clinical Practice Guidelines in Oncology (2015) (0)
Assessment of cancer screening practices after BRCA testing in Michigan. (2013) (0)
PD48-06 DETECTION OF GERMLINE MUTATIONS IN LOCALIZED AND METASTATIC PROSTATE CANCER THROUGH GUIDLINE-BASED TESTING (2020) (0)
IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases (2022) (0)
Perspective Cancer Prevention Research One-Hit Effects and Cancer (2009) (0)
MP24-02 SATISFACTION WITH CLINICIAN-LED GERMLINE GENETIC COUNSELING IN MEN WITH PROSTATE CANCER (2021) (0)
Disparities in genetic services utilization in a random sample of young breast cancer survivors (2018) (0)
Absence of the CHEK2*1100delC mutation in non-BRCA1/2 families with multiple cancer types in a high-risk clinic population of Caucasian ancestry. (2009) (0)
Test of an online tool to facilitate NCCN guideline-compliant access to cancer genetics care. (2020) (0)
Abstract 2996: Creating PDXs from continental African breast tumors: addressing racial inequity through science (2021) (0)
Patient reported function and symptom burden in breast cancer patients with CNS metastases. (2022) (0)
Defining the Smallest Common Region of Chromosome 17p that is Deleted in Sporadic Breast Tumors (1997) (0)
Reply by Authors. (2020) (0)
The Srivastava/McKinnon/Wood article reviewed (2001) (0)
Public and Professional Educational Needs for Downstaging Breast Cancer in Egypt (2011) (0)
KNOWLEDGE OF RISK FACTORS AND GENE TRANSMISSION AMONG WOMEN AT RISK FOR HBOC (2012) (0)
PCN12 Meta Analytic Comparison of Breast Cancer Risk in Diabetic Women: Important Differences Between Asian and Caucasian Women Suggest Risk Management Startegies (2012) (0)
BPI20-008: Pilot Testing of InheRET™, an Online Tool to Facilitate NCCN Guideline®-Compliant Referrals for Cancer Genetic Counseling and Increase Access to Care (2020) (0)
Preoperative chemoradiation and postoperative adjuvant tetrathiomolybdate for patients with resectable esophageal cancer. (2016) (0)
Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening (2013) (0)
Genetic risk assessment in primary care settings: An evaluation of NCCN guidelines. (2022) (0)
Impact of increased understanding of personal and family health history on patients. (2020) (0)
Testing biomarkers: Designing trials as if we believed in them! (2007) (0)
Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer. (2021) (0)
EUS and MRI/MRCP Findings in Pancreatic Cancer Screening for Individuals Who Harbor a BRCA2 Deleterious Germline Mutation: 31 (2016) (0)
Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study (2017) (0)
Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer? (2020) (0)
Opportunities for Molecular Pathology Research (2013) (0)
Structure and Function of BRCA Genes (2000) (0)
Implementation of strategies to increase genetic counseling referral rates for ovarian cancer patients. (2018) (0)

This paper list is powered by the following services:

Other Resources About Sofia Merajver

en.wikipedia.org

What Schools Are Affiliated With Sofia Merajver?

Sofia Merajver is affiliated with the following schools:

Sofia Merajver's Academic­Influence.com Rankings